173 related articles for article (PubMed ID: 22837671)
1. By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.
Deramchia K; Jacobin-Valat MJ; Laroche-Traineau J; Bonetto S; Sanchez S; Dos Santos P; Massot P; Franconi JM; Martineau P; Clofent-Sanchez G
Int J Mol Sci; 2012; 13(6):6902-6923. PubMed ID: 22837671
[TBL] [Abstract][Full Text] [Related]
2. In vivo phage display to identify new human antibody fragments homing to atherosclerotic endothelial and subendothelial tissues [corrected].
Deramchia K; Jacobin-Valat MJ; Vallet A; Bazin H; Santarelli X; Sanchez S; Dos Santos P; Franconi JM; Claverol S; Bonetto S; Clofent-Sanchez G
Am J Pathol; 2012 Jun; 180(6):2576-89. PubMed ID: 22521648
[TBL] [Abstract][Full Text] [Related]
3. A fully human scFv phage display library for rapid antibody fragment reformatting.
Li K; Zettlitz KA; Lipianskaya J; Zhou Y; Marks JD; Mallick P; Reiter RE; Wu AM
Protein Eng Des Sel; 2015 Oct; 28(10):307-16. PubMed ID: 25991864
[TBL] [Abstract][Full Text] [Related]
4. Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study.
Jalilzadeh-Razin S; Mantegi M; Tohidkia MR; Pazhang Y; Pourseif MM; Barar J; Omidi Y
Daru; 2019 Jun; 27(1):21-34. PubMed ID: 30607886
[TBL] [Abstract][Full Text] [Related]
5. Identification of human scFvs targeting atherosclerotic lesions: selection by single round in vivo phage display.
Robert R; Jacobin-Valat MJ; Daret D; Miraux S; Nurden AT; Franconi JM; Clofent-Sanchez G
J Biol Chem; 2006 Dec; 281(52):40135-43. PubMed ID: 17068330
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Human Single-Chain Fragment Variable Phage Display-Assisted Identification of Galectin-3 as a New Biomarker of Atherosclerosis.
Hemadou A; Fontayne A; Laroche-Traineau J; Ottones F; Mondon P; Claverol S; Ducasse É; Sanchez S; Mohamad S; Lorenzato C; Duonor-Cerutti M; Clofent-Sanchez G; Jacobin-Valat MJ
J Am Heart Assoc; 2021 Oct; 10(19):e016287. PubMed ID: 34569248
[TBL] [Abstract][Full Text] [Related]
7. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
Tohidkia MR; Asadi F; Barar J; Omidi Y
BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
[TBL] [Abstract][Full Text] [Related]
8. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
9. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
10. An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis.
Hemadou A; Laroche-Traineau J; Antoine S; Mondon P; Fontayne A; Le Priol Y; Claverol S; Sanchez S; Cerutti M; Ottones F; Clofent-Sanchez G; Jacobin-Valat MJ
Sci Rep; 2018 Oct; 8(1):15016. PubMed ID: 30302027
[TBL] [Abstract][Full Text] [Related]
11. Generation of a highly reactive chicken-derived single-chain variable fragment against Fusarium verticillioides by phage display.
Hu ZQ; Liu JL; Li HP; Xing S; Xue S; Zhang JB; Wang JH; Nölke G; Liao YC
Int J Mol Sci; 2012; 13(6):7038-7056. PubMed ID: 22837678
[TBL] [Abstract][Full Text] [Related]
12. A comparison of three strategies for biopanning of phage-scFv library against diphtheria toxin.
Lakzaei M; Rasaee MJ; Fazaeli AA; Aminian M
J Cell Physiol; 2019 Jun; 234(6):9486-9494. PubMed ID: 30417355
[TBL] [Abstract][Full Text] [Related]
13. Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form.
Kaku Y; Noguchi A; Okutani A; Inoue S; Tanabayashi K; Yamamoto Y; Hotta A; Suzuki M; Sugiura N; Yamada A
BMC Res Notes; 2012 Sep; 5():483. PubMed ID: 22943792
[TBL] [Abstract][Full Text] [Related]
14. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
15. Generation and analysis of the improved human HAL9/10 antibody phage display libraries.
Kügler J; Wilke S; Meier D; Tomszak F; Frenzel A; Schirrmann T; Dübel S; Garritsen H; Hock B; Toleikis L; Schütte M; Hust M
BMC Biotechnol; 2015 Feb; 15():10. PubMed ID: 25888378
[TBL] [Abstract][Full Text] [Related]
16. A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments.
Perween R; Ahmed S; Shrivastava T; Parray HA; Singh B; Pindari KS; Sharma C; Shukla S; Sinha S; Panchal AK; Kumar R
Biotechnol Prog; 2021 May; 37(3):e3136. PubMed ID: 33620776
[TBL] [Abstract][Full Text] [Related]
17. Efficient and robust isolation of rabbit scFv antibodies using antigen-coupled multilamellar vesicles.
Kumada Y; Hasegawa Y; Horiuchi JI
J Biosci Bioeng; 2021 Mar; 131(3):299-304. PubMed ID: 33221176
[TBL] [Abstract][Full Text] [Related]
18. Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology.
Rahbarnia L; Farajnia S; Babaei H; Majidi J; Veisi K; Tanomand A; Akbari B
Biologicals; 2016 Nov; 44(6):567-573. PubMed ID: 27520285
[TBL] [Abstract][Full Text] [Related]
19. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
Kato M; Hanyu Y
J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
[TBL] [Abstract][Full Text] [Related]
20. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
